Sinsin Pharmaceutical Co. Ltd (002800) — Financial Flexibility Index
Sinsin Pharmaceutical Co. Ltd (002800) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of ₩5.57 Billion (operating CF ₩4.70 Billion minus capex ₩871.54 Million) represents 0% of total liabilities (₩65.10 Billion). Check 002800 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinsin Pharmaceutical Co. Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sinsin Pharmaceutical Co. Ltd across 9 annual periods. See 002800 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sinsin Pharmaceutical Co. Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Sinsin Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see Sinsin Pharmaceutical Co. Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | ₩7.46 Billion | ₩5.94 Billion | ₩63.61 Billion | ▼ -18.4% |
| 2023 | 0.14x | ₩8.96 Billion | ₩3.93 Billion | ₩62.32 Billion | ▲ +38.9% |
| 2022 | 0.10x | ₩6.37 Billion | ₩5.46 Billion | ₩61.52 Billion | ▲ +127.2% |
| 2021 | 0.05x | ₩2.71 Billion | ₩23.18 Million | ₩59.38 Billion | ▼ -79.6% |
| 2020 | 0.22x | ₩13.83 Billion | ₩1.87 Billion | ₩61.94 Billion | ▲ +1.7% |
| 2019 | 0.22x | ₩16.00 Billion | ₩-4.51 Billion | ₩72.87 Billion | ▼ -55.3% |
| 2018 | 0.49x | ₩26.21 Billion | ₩774.24 Million | ₩53.38 Billion | ▲ +61.3% |
| 2017 | 0.30x | ₩8.14 Billion | ₩4.57 Billion | ₩26.74 Billion | ▲ +2.4% |
| 2016 | 0.30x | ₩10.22 Billion | ₩2.79 Billion | ₩34.38 Billion | — |